DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "U.S. Scar Treatment Market Size, Share, Development, Growth and Demand Forecast to 2020" report to their offering.
The U.S. scar treatment market accounted for $4,757.8 million revenue in 2014, and it is expected to grow with a CAGR of 10.2% during 2015-2020. The products segment dominated the U.S. market in 2014 with about 59.4% share; whereas, among the various therapies, the dermabrasion segment accounted for the highest share of 25.6% in the U.S. scar treatment market in the same year. The U.S. scar treatment market is witnessing high growth rate due to growing cases of skin problems leading to scar formation, availability of technologically advanced products that have the capability to fade away the scars, and increasing appearance consciousness among consumers. Also, the increasing expenditure on personal care is further propelling the growth of the market.
The key companies operating in the U.S. scar treatment market include MerzPharma, Valeant Pharmaceuticals International Inc., Pacific World Corporation, Oculus Innovative Sciences, Inc. Enaltus, LLC, Johnson & Johnson Services, Inc., CCA Industries Inc., Revitol Corporation Inc., Scarguard Labs LLC, and Quantum Health.
Key Topics Covered:
1. Research Scope & Methodology
4.U.S. Scar Treatment Market, By Segment
5.U.S. Scar Treatment Market, By Type Of Scar
6.Competitive Positioning And Market Share Analysis
7.Company Profiles And Strategic Developments
For more information about this report visit http://www.researchandmarkets.com/research/mllmbm/u_s_scar